Full-Time

Sales Territory Manager

Lightforce

Posted on 11/23/2025

ENOVIS

ENOVIS

1,001-5,000 employees

Global medical technology company; orthopedic solutions

No salary listed

North Carolina, USA

In Person

Field-based; up to 75% travel; requires travel by car and air.

Category
Sales & Account Management (1)
Required Skills
Sales
Word/Pages/Docs
Salesforce
Customer Service
Excel/Numbers/Sheets
PowerPoint/Keynote/Slides
Requirements
  • Minimum of 3 years of experience in Sales or relevant Customer Service.
  • Minimum Bachelor’s degree or equivalent combination of education and experience.
  • Travel up to 75% of the time, with occasional overnight travel up to 5 days.
  • Field based work environment; must be able to walk, sit or stand for long periods of time, climb stairs, lift up to 50 lbs. into and out of a vehicle, up to 10 times per day.
  • Air travel as needed based on territory needs.
  • Proficient computer system-based tools including Microsoft Office applications, presentation, e-mail, web browsers and spreadsheet software.
  • Working Knowledge of Microsoft Outlook, Word, Excel, PowerPoint, Teams applications and Salesforce platform.
  • Ability to communicate effectively at all levels of the organization, both verbally and in writing.
  • Interpersonal skills to interact with co-workers and customers at all levels.
  • Presentation skills to present 1:1 or in group settings.
  • Initiative to work independently, prioritize workload, manage multiple priorities, and establish new processes.
  • Problem solving ability to use rigorous logic and cross-functional expertise to address problems.
  • Decision making with creativity and good judgment to meet business objectives.
  • Adaptability to change and willingness to learn; prioritize actions to meet customer needs.
  • Trust and integrity in professional conduct; keep commitments.
  • Collaborative and team-oriented attitude; ability to work cross-functionally.
  • Customer orientation with understanding of various customers’ needs and providing solutions.
  • Business acumen and understanding of current practices and trends; cross-functional knowledge.
  • Global/business perspective with cross-functional knowledge.
  • Ability to travel up to 75% and work in field environments similar to physician offices, hospitals, and clinics.
  • Must be able to operate and use company systems and comply with regulatory requirements.
Responsibilities
  • Achieve assigned company goals and objectives through sales to designated accounts.
  • Cultivate customer relationships by initiating contact with physicians, clinic staff, and other device users.
  • Understand the competitive landscape, trends in the industry, and the Company’s position in the market.
  • Be layperson expert concerning clinical science and Enovis platforms’ mechanisms of action.
  • Demonstration and education on technical and clinical aspects of products to customers, prospective customers, and patients.
  • Coordinate company technical engineering services to develop solutions to customers’ needs.
  • Prepare price quotations, communicate, and negotiate terms and conditions of sales within limits of authority.
  • Write orders subject to company policy.
  • Assist with equipment delivery, setup, follow-up, and service as needed.
  • Support network of key professionals and related personnel to educate referrals on Enovis products.
  • Facilitate local educational and sales events, with the support of other internal resources, to augment the business presence.
  • Attend national, regional, state and local tradeshows and conferences.
  • Expand usage of Lightforce Laser & Chattanooga Shockwave administrations.
  • Develop and execute a business plan designed to exceed financial, market, and product portfolio goals for assigned territory.
  • Utilize Salesforce to maintain up to date contacts, opportunities, targets, and outcomes.
  • Maintain sales funnel for sustained opportunities.
  • Maintain comprehensive and effective strategic call plans that drive positive sales results.
  • Schedule and prioritize time for effective territory coverage.
  • Effectively manage leads: Identify, qualify, and cultivate new sales opportunities.
  • Responsible for performing region penetration coverage and account identification to drive sales and increase customer base.
  • Pre-plans sales calls and maintains efficient time management to ensure maximum customer contact and service.
  • Drives sales through indirect sales channels.
  • Develops and maintains key customer relationships to achieve account objectives.
  • Takes responsibility for customer satisfaction and loyalty.
  • Responds to customer needs and concerns to resolve issues quickly.
  • Effectively manages customer and dealer relationships to meet sales revenue objectives.
  • Fosters strong relationships with Regional Account Managers (Chattanooga) and dealer network.
  • Proactively cultivates competitive opportunities that result in converted business.
  • Defends competitive threats to minimize losses.
  • Identifies underlying problems affecting organizational or individual performance such as market conditions, competitor actions, or other external forces.
  • Provides presentations and demonstrations to the customer on application and use of Enovis products using effective communication and sales techniques.
  • Demonstrates commitment to the Enovis Compliance & Ethics Program, the Enovis Code of Conduct, the Enovis Sales and Marketing Code of Conduct, the AdvaMed Code of Ethics, and all supporting and applicable regulations, policies, and procedures.
  • Treats Protected Health Information (PHI) with the strictest confidentiality in accordance with HIPAA standards.
  • Acquires a basic understanding of the field to include regulatory compliance issues and adhere to these guidelines.
  • Completes administrative responsibilities in an accurate and timely manner. Completes tasks assigned as well as expense reports, surveys, business plans, regional reports, training records, etc. Develops or uses systems to organize and track information.

Enovis develops medical devices and services to improve patient outcomes and restore mobility. It operates Prevention & Recovery with orthopedic braces, soft goods, vascular therapy, compression garments, and hot/cold therapy, and Reconstructive with joint implants and surgical tools such as Novastep. It differentiates itself through a broad clinically oriented portfolio, a global footprint, and the EGX continuous improvement program, plus the LimaCorporate acquisition expanding its transatlantic reach. Its goal is to provide better patient outcomes and mobility worldwide through sustained growth and operational excellence.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Wilmington, Delaware

Founded

2022

Simplify Jobs

Simplify's Take

What believers are saying

  • Extremities segment achieves 10% organic growth led by double-digit shoulder gains.
  • ARVIS robot deployment starts with South Africa procedure, adoption expands through 2026.
  • BTIG initiates Buy rating with $41 target on new launches in hips and knees.

What critics are saying

  • $1.18B goodwill impairment from LimaCorporate overpayment erodes R&D capital now.
  • Stryker Mako captures 60% US robotic shoulder procedures, blocks ARVIS adoption by 2027.
  • Zimmer Biomet Persona IQ steals Nebula conversions, slows recon growth by mid-2027.

What makes ENOVIS unique

  • Enovis leverages Enovis Growth Excellence system for continuous operational improvements.
  • Enovis offers ARVIS shoulder robot and Augmented Reverse Glenoid System for extremities.
  • Enovis integrates LimaCorporate acquisition to expand reconstructive implant portfolio.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at ENOVIS who can refer or advise you

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Paid Vacation

Paid Sick Leave

Paid Holidays

Legal Services

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

32%
Yahoo Finance
Feb 28th, 2026
Enovis reports strong revenue growth and new device uptake despite $1.18B goodwill impairment

Enovis Corporation has reported strong organic revenue growth driven by new product launches, including the Nebula Stem and OrthoDrive Impactor, which have seen rapid market uptake. The medical technology company's devices are gaining traction with surgeons and hospitals. However, Enovis recorded a significant goodwill impairment charge in its fourth quarter and full-year results, affecting its balance sheet. The impairment raises questions about returns from previous acquisitions and future capital allocation strategy. Trading at $25.47, Enovis shares are approximately 44% below the analyst price target of $45.18. The company currently shows a loss of $1.18 billion and trades at a forward price-to-earnings ratio of 25.73 times. Investors are advised to monitor how product adoption and procedure volumes affect future cash flow.

Yahoo Finance
Feb 26th, 2026
Enovis stock jumps 12.6% on strong 2026 earnings forecast despite Q4 revenue miss

Enovis Corporation shares jumped 12.6% in morning trading after the medical technology company reported mixed fourth-quarter results but issued a strong earnings forecast for 2026. Whilst quarterly revenue of approximately $576 million missed expectations, adjusted earnings per share of $0.95 beat analyst estimates. The stock surge was driven by Enovis's 2026 earnings guidance of $3.52 to $3.73 per share, with the midpoint significantly exceeding analyst projections. This positive profit outlook overshadowed the revenue shortfall. Enovis shares have experienced high volatility, with 26 moves exceeding 5% over the past year. The stock is down 6.6% year-to-date and trading 38.1% below its 52-week high of $40 from March 2025.

Yahoo Finance
Feb 26th, 2026
Enovis reports $520.6M Q4 loss despite adjusted earnings of 95 cents per share

Enovis Corporation reported a fourth-quarter loss of $520.6 million, or $9.10 per share. The Wilmington, Delaware-based manufacturing and engineering company posted adjusted earnings of 95 cents per share, excluding asset impairment and non-recurring costs. Revenue for the quarter reached $575.8 million. For the full year, Enovis reported a loss of $1.18 billion, or $20.75 per share, on revenue of $2.25 billion.

Yahoo Finance
Jan 23rd, 2026
BTIG initiates Enovis with $41 target as orthopedic tech firm eyes growth from new product launches

Enovis Corporation has received positive analyst coverage, with BTIG initiating a Buy rating and $41 price target on 6 January. The orthopedic care company is expected to see accelerated growth in 2026 driven by new product launches across extremities, hips and knees. BTIG highlighted the company's consistent mid-to-high single-digit organic revenue growth in its Reconstruction and Prevention & Recovery segments. The higher-growth Reconstruction business is expected to drive margins whilst the mature Prevention & Recovery segment delivers steady cash flow. UBS maintained its Buy rating but lowered its price target to $50 from $57, projecting sales of $2.26 billion in 2025, $2.37 billion in 2026 and $2.52 billion in 2027.

TradingView
Dec 10th, 2025
Enovis secures $700M term loan and $1.1B credit facility, extends maturity to 2030

Enovis Corp has entered Amendment No. 3 to its credit agreement on 8 December, extending the loan maturity date to 8 December 2030. The amended agreement provides a revolving credit facility of up to $1.1 billion and a term loan facility of $700 million. The company used term loan proceeds to repay $335 million from its revolving facility. The amendment restructures Enovis's debt arrangements, providing the medical technology company with extended financing flexibility through the end of the decade.

INACTIVE